학술논문

BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response - results from the NSCLC cohort
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1025-pS1025, 1p. Supplement: 7
Subject
Language
English
ISSN
15698041